Assessment of compartment-specific CD103-positive cells for prognosis prediction of colorectal cancer
This study supported a phenotypic heterogeneity of CD103<sup>+</sup> cells in CRC, and provided a reliable estimate of the risk of death and recurrence in CRC patients based on combined analysis of CD103<sup>+</sup> cells within 3 intratumor compartments.
Authors
- Yuanhui Wu (ORCID: https://orcid.org/0000-0002-7004-1663)
- Muyan Cai (ORCID: https://orcid.org/0000-0002-4646-4391)
- Yumo Xie
- Ji Cui (ORCID: https://orcid.org/0000-0001-8905-8513)
- Meijin Huang (ORCID: https://orcid.org/0000-0002-5483-4591)
- Pinzhu Huang (ORCID: https://orcid.org/0000-0002-8339-9701)
- Jialin Zou
- Anpei Huang (ORCID: https://orcid.org/0000-0003-0846-5796)
- Hui Yang (ORCID: https://orcid.org/0000-0002-5961-6155)
- Maram Alenzi
Institutions
- Beth Israel Deaconess Medical Center (US)
- Sun Yat-sen University (CN)
- Longgang Central Hospital (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sun Yat-sen University Cancer Center (CN)
Publication Details
- Journal
- Cancer Immunology Immunotherapy
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1007/s00262-025-04087-z
- Citations
- 1
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Natural Science Foundation of Guangdong Province